tiprankstipranks
Avenue Therapeutics Inc (ATXI)
OTHER OTC:ATXI
US Market
ATXI
Avenue Therapeutics
RESEARCH TOOLSreports

Avenue Therapeutics (ATXI) Financial Statements

331 Followers

Avenue Therapeutics Financial Overview

Avenue Therapeutics's market cap is currently $1.48M. The company's EPS TTM is $; its P/E ratio is -0.73; Avenue Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 1.40M$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 1.40M$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -3.29M$ -11.28M$ -14.54M$ -8.04M$ -3.74M
EBITDA$ -3.29M$ -11.70M$ 4.05M$ -2.44M$ 7.00K
Net Income$ -2.91M$ -11.65M$ -10.38M$ -3.55M$ -3.73M
Balance Sheet
Cash & Short-Term Investments$ 2.85M$ 2.59M$ 1.78M$ 6.71M$ 3.76M
Total Assets$ 2.93M$ 2.67M$ 1.85M$ 6.84M$ 3.96M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -2.85M$ -2.59M$ -1.78M$ -6.71M$ -3.76M
Total Liabilities$ 1.10M$ 816.00K$ 1.20M$ 3.58M$ 509.00K
Stockholders' Equity$ 1.83M$ 2.80M$ 1.58M$ 3.90M$ 3.45M
Cash Flow
Free Cash Flow$ -1.83M$ -9.03M$ -12.45M$ -7.60M$ -3.75M
Operating Cash Flow$ -1.83M$ -9.03M$ -9.45M$ -7.60M$ -3.75M
Investing Cash Flow$ 0.00$ 0.00$ -3.00M$ 0.00$ 0.00
Financing Cash Flow$ 2.09M$ 9.84M$ 7.53M$ 10.54M$ 4.38M
Currency in USD

Avenue Therapeutics Earnings and Revenue History

Income Statement >

Avenue Therapeutics Debt to Assets

Balance Sheet >

Avenue Therapeutics Cash Flow

Cash Flow >

Avenue Therapeutics Forecast EPS vs Actual EPS

Earnings >